Pfizer Inc. (NYSE: PFE) announced today that the company will begin shipment of INFLECTRA® (infliximab-dyyb)for injection, a biosimilar of REMICADE®1 ...(Premium-only article. Please sign in or upgrade to SI Premium to view.)